Sex-specific effect of antenatal betamethasone exposure on renal oxidative stress induced by angiotensins in adult sheep

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 9, 2014, Pages F1013-F1022

  Bi, Jianli ^a   Contag, Stephen A ^b   Chen, Kai ^a   Su, Yixin ^a   Figueroa, Jorge P ^a   Chappell, Mark C ^a   Rose, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

8 isoprostane; Fetal programming; Intrarenal infusion; Kidney; Proteinuria

Indexed keywords

8 ISOPROSTANE; ANGIOTENSIN II; ANGIOTENSIN[1-7]; BETAMETHASONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; 8-EPI-PROSTAGLANDIN F2ALPHA; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN I (1-7); GLUCOCORTICOID; PEPTIDE FRAGMENT; PROSTAGLANDIN F2 ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; FEMALE; GESTATION PERIOD; IN VITRO STUDY; IN VIVO STUDY; INTRARENAL DRUG ADMINISTRATION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; OXIDATIVE STRESS; PRENATAL PERIOD; PRIMARY CULTURE; PROTEINURIA; SHEEP; UNINEPHRECTOMY; URINARY EXCRETION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SEX DIFFERENCE; URINE;

ANGIOTENSIN I; ANGIOTENSINS; ANIMALS; BETAMETHASONE; DINOPROST; FEMALE; GLUCOCORTICOIDS; KIDNEY; MALE; NADPH OXIDASE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEINURIA; SEX FACTORS; SHEEP; SUPEROXIDE DISMUTASE;

EID: 84908386458     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00354.2014     Document Type: Article

References (74)

1. Authors not listed. NIH Consensus Development Conference 1995. Effects of corticosteroid for fetal maturation on perinatal outcomes. JAMA 273: 413-418, 1995.
2. Abitbol CL, Ingelfinger JR. Nephron mass and cardiovascular and renal disease risks. Semin Nephrol 29: 445-454, 2009.
3. Araujo M, Wilcox CS. Oxidative stress in hypertension: role of the kidney. Antioxid Redox Signal 20: 74-101, 2014.
4. Babior BM. NADPH oxidase. Curr Opin Immunol 16: 42-47, 2004.
5. Baum M. Role of the kidney in the prenatal and early postnatal programming of hypertension. Am J Physiol Renal Physiol 298: F235-F247, 2010.
6. Benter IF, Yousif MH, Dhaunsi GS, Kaur J, Chappell MC, Diz DI. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28: 25-33, 2008.
7. Bi J, Contag SA, Carey LC, Tang L, Valego NK, Chappell MC, Rose JC. Antenatal betamethasone exposure alters renal responses to angiotensin-(1-7) in uninephrectomized adult male sheep. J Renin Angiotensin Aldosterone Syst 14: 290-298, 2013.
8. Bonanno C, Wapner RJ. Antenatal corticosteroid treatment: what's happened since Drs Liggins and Howie? Am J Obstet Gynecol 200: 448-457, 2009.
9. Boubred F, Saint-Faust M, Buffat C, Ligi I, Grandvuillemin I, Simeoni U. Developmental origins of chronic renal disease: an integrative hypothesis. Int J Nephrol 2013: 346067, 2013.
10. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002.
11. Chapman K, Holmes M, Seckl J. 11-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 93: 1139-1206, 2013.
12. Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS receptor axis: more than regulation of blood pressure? Hypertension 50: 596-599, 2007.
13. Chappell MC, Marshall AC, Alzayadneh EM, Shaltout HA, Diz DI. Update on the angiotensin converting enzyme 2-angiotensin (1-7)-Mas receptor axis: fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne) 4: 201, 2014.
14. Christensen EI, Birn H, Rippe B, Maunsbach AB. Controversies in nephrology: renal albumin handling, facts, and artifacts. Kidney Int 72: 1192-1194, 2007.
15. Christensen EI, Birn H, Storm T, Weyer K, Nielsen R. Endocytic receptors in the renal proximal tubule. Physiology (Bethesda) 27: 223- 236, 2012.
16. Comper WD, Haraldsson B, Deen WM. Resolved: normal glomeruli filter nephrotic levels of albumin. J Am Soc Nephrol 19: 427-432, 2008.
17. Comper WD, Hilliard LM, Nikolic-Paterson DJ, Russo LM. Diseasedependent mechanisms of albuminuria. Am J Physiol Renal Physiol 295: F1589-F1600, 2008.
18. Contag SA, Bi J, Chappell MC, Rose JC. Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep. Am J Physiol Renal Physiol 298: F847-F856, 2010.
19. Dilauro M, Burns KD. Angiotensin-(1-7) and its effects in the kidney. Scientific World J 9: 522-535, 2009.
20. Dodic M, May CN, Wintour EM, Coghlan JP. An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep. Clin Sci (Lond) 94: 149-155, 1998.
21. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond) 98: 137-142, 2000.
22. Fam SS, Morrow JD. The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 10: 1723-1740, 2003.
23. Fan L, Mukaddam-Daher S, Javeshghani D, Quillen E, Jr., Gutkowska J. Renal effects of prolonged intrarenal infusions of angiotensin II and atrial natriuretic peptide in sheep. J Cardiovasc Pharmacol 34: 427-433, 1999.
24. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196: 147-148, 2007.
25. Franco MC, Kawamoto EM, Gorjao R, Rastelli VM, Curi R, Scavone C, Sawaya AL, Fortes ZB, Sesso R. Biomarkers of oxidative stress and antioxidant status in children born small for gestational age: evidence of lipid peroxidation. Pediatr Res 62: 204-208, 2007.
26. 2 -), superoxide dismutases, and related matters. J Biol Chem 272: 18515-18517, 1997.
27. Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158, 2009.
28. Gonzales S, Noriega GO, Tomaro ML, Pena C. Angiotensin-(1-7) stimulates oxidative stress in rat kidney. Regul Pept 106: 67-70, 2002.
29. Gwathmey TM, Shaltout HA, Rose JC, Diz DI, Chappell MC. Glucocorticoid- induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney. Hypertension 57: 620- 626, 2011.
30. Hosojima M, Sato H, Yamamoto K, Kaseda R, Soma T, Kobayashi A, Suzuki A, Kabasawa H, Takeyama A, Ikuyama K, Iino N, Nishiyama A, Thekkumkara TJ, Takeda T, Suzuki Y, Gejyo F, Saito A. Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk. Endocrinology 150: 871-878, 2009.
31. Ingelfinger JR. Disparities in renal endowment: causes and consequences. Adv Chronic Kidney Dis 15: 107-114, 2008.
32. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007.
33. Liu GC, Fang F, Zhou J, Koulajian K, Yang S, Lam L, Reich HN, John R, Herzenberg AM, Giacca A, Oudit GY, Scholey JW. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse. Diabetologia 55: 2522-2532, 2012.
34. Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382: 273-283, 2013.
35. Mahadevappa R, Nielsen R, Christensen EI, Birn H. Megalin in acute kidney injury: foe and friend. Am J Physiol Renal Physiol 306: F147- F154, 2014.
36. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ, Mathews TJ. Birth: final data for 2011. Natl Vital Stat Rep 62: 1-69, 72, 2013.
37. Massmann GA, Zhang J, Rose JC, Figueroa JP. Acute and long-term effects of clinical doses of antenatal glucocorticoids in the developing fetal sheep kidney. J Soc Gynecol Investig 13: 174-180, 2006.
38. Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 10, Suppl 1: S10-S23, 2005.
39. Mori J, Patel VB, Ramprasath T, Alrob OA, DesAulniers J, Scholey JW, Lopaschuk GD, Oudit GY. Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity. Am J Physiol Renal Physiol 306: F812- F821, 2014.
40. Morrow JD. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 32: 377-385, 2000.
41. Nenov VD, Taal MW, Sakharova OV, Brenner BM. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 9: 85-97, 2000.
42. Nielsen R, Christensen EI. Proteinuria and events beyond the slit. Pediatr Nephrol 25: 813-822, 2010.
43. Nistala R, Wei Y, Sowers JR, Whaley-Connell A. Renin-angiotensinaldosterone system-mediated redox effects in chronic kidney disease. Transl Res 153: 102-113, 2009.
44. Nuyt AM. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin Sci (Lond) 114: 1-17, 2008.
45. Ojeda NB, Intapad S, Alexander BT. Sex differences in the developmental programming of hypertension. Acta Physiol (Oxf) 2013. doi: 10.1111/apha.12206.
46. Ojeda NB. Low birth weight increases susceptibility to renal injury in a rat model of mild ischemia-reperfusion. Am J Physiol Renal Physiol 301: F420-F426, 2011.
47. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int 59: 1663-1669, 2001.
48. Paixao AD, Alexander BT. How the kidney is impacted by the perinatal maternal environment to develop hypertension. Biol Reprod 89: 144, 2013.
49. Passos-Silva DG, Verano-Braga T, Santos RA. Angiotensin-(1-7): beyond the cardio-renal actions. Clin Sci (Lond) 124: 443-456, 2013.
50. Polyakov A, Cohen S, Baum M, Trickey D, Jolley D, Wallace EM. Patterns of antenatal corticosteroid prescribing 1998-2004. Aust N Z J Obstet Gynaecol 47: 42-45, 2007.
51. Reynolds RM. Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes. J Steroid Biochem Mol Biol 122: 3-9, 2010.
52. Reynolds RM. Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis-2012 Curt Richter Award Winner. Psychoneuroendocrinology 38: 1-11, 2013.
53. Reynolds RM, Jacobsen GH, Drake AJ. What is the evidence in humans that DNA methylation changes link events in utero and later life disease? Clin Endocrinol (Oxf) 78: 814-822, 2013.
54. Russo LM, Sandoval RM, Brown D, Molitoris BA, Comper WD. Controversies in nephrology: response to "renal albumin handling, facts, and artifacts". Kidney Int 72: 1195-1197, 2007.
55. Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71: 504-513, 2007.
56. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol 18: 2439-2446, 2007.
57. Saez F, Castells MT, Zuasti A, Salazar F, Reverte V, Loria A, Salazar FJ. Sex differences in the renal changes elicited by angiotensin II blockade during the nephrogenic period. Hypertension 49: 1429-1435, 2007.
58. Saez F, Reverte V, Salazar F, Castells MT, Llinas MT, Salazar FJ. Hypertension and sex differences in the age-related renal changes when cyclooxygenase-2 activity is reduced during nephrogenesis. Hypertension 53: 331-337, 2009.
59. Sampaio WO, Henrique de CC, Santos RA, Schiffrin EL, Touyz RM. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50: 1093-1098, 2007.
60. Shaltout HA, Rose JC, Chappell MC, Diz DI. Angiotensin-(1-7) deficiency and baroreflex impairment precede the antenatal betamethasone exposure-induced elevation in blood pressure. Hypertension 59: 453-458, 2012.
61. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, Rose JC, Chappell MC. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292: F82-F91, 2007.
62. Shaltout HA, Rose JC, Figueroa JP, Chappell MC, Diz DI, Averill DB. Acute AT1-receptor blockade reverses the hemodynamic and baroreflex impairment in adult sheep exposed to antenatal betamethasone. Am J Physiol Heart Circ Physiol 299: H541-H547, 2010.
63. Singh RR, Cuffe JS, Moritz KM. Short- and long-term effects of exposure to natural and synthetic glucocorticoids during development. Clin Exp Pharmacol Physiol 39: 979-989, 2012.
64. Tang L, Bi J, Valego N, Carey L, Figueroa J, Chappell M, Rose JC. Prenatal betamethasone exposure alters renal function in immature sheep: sex differences in effects. Am J Physiol Regul Integr Comp Physiol 299: R793-R803, 2010.
65. Tang L, Carey LC, Bi J, Valego N, Sun X, Deibel P, Perrott J, Figueroa JP, Chappell MC, Rose JC. Gender differences in the effects of antenatal betamethasone exposure on renal function in adult sheep. Am J Physiol Regul Integr Comp Physiol 296: R309-R317, 2009.
66. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 323: 85-93, 2007.
67. Vehaskari VM. Developmental origins of adult hypertension: new insights into the role of the kidney. Pediatr Nephrol 22: 490-495, 2007.
68. Vehaskari VM. Prenatal programming of kidney disease. Curr Opin Pediatr 22: 176-182, 2010.
69. Vehaskari VM, Woods LL. Prenatal programming of hypertension: lessons from experimental models. J Am Soc Nephrol 16: 2545-2556, 2005.
70. Welch WJ. Angiotensin II-dependent superoxide: effects on hypertension and vascular dysfunction. Hypertension 52: 51-56, 2008.
71. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-R935, 2005.
72. Yagil Y, Hessner M, Schulz H, Gosele C, Lebedev L, Barkalifa R, Sapojnikov M, Hubner N, Yagil C. Geno-transcriptomic dissection of proteinuria in the uninephrectomized rat uncovers a molecular complexity with sexual dimorphism. Physiological Genomics 42A: 301- 316, 2010.
73. Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 47: 502-508, 2006.
74. Zhang J, Massman GA, Rose JC, Figueroa JP. Differential effects of a clinical dose of betamethasone on nephron endowment and glomerular filtration in adult sheep. Repro Sci 17: 186-195, 2009.